Publikationen der ABCSG 2005-2001

Finden Sie hier eine Übersicht zu peer-reviewed Fachpublikationen (Vollpublikationen), an denen die ABCSG maßgeblich beteiligt war

2005

Clinical role of multidrug resistance protein 1 expression in chemotherapy resistance in early-stage breast cancer: the Austrian Breast and Colorectal Cancer Study Group

Filipits M, Pohl G, Rudas M, Dietze O, Lax S, Grill R, Pirker R, Zielinski C, Hausmaninger H, Kubista E, Samonigg H, Jakesz R

Journal of Clinical Oncology

https://www.ncbi.nlm.nih.gov/pubmed/15718312


Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years‘ adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial

Jakesz R, Jonat W, Gnant M, Mittlböck M, Greil R, Tausch Ch, Hilfrich J, Kwasny W, Menzel Ch, Samonigg H, Seifer M, Gademann G, Kaufmann M

The Lancet

https://www.ncbi.nlm.nih.gov/pubmed/16084253


Trastuzumab after Adjuvant Chemotherapy in HER2-positive Breast Cancer

Piccart-Gebhart M, Procter M, Leyland-Jones B, Goldhirsch A, Untch M, Smith I, Gianni L, Baselga J, Bell R, Jackisch C, Cameron D, Dowsett M, Barrios C, Steger G, Huang C, Andersson M, Inbar M, Lichinitser M, Láng I, Nitz U, Iwata H, Thomssen C, Lorisch C, Suter T, Rüschoff J, Süt´ö, Greatorex V, Ward C, Straehle C, McFadden E, Dolci S, Gelber S

The New England Journal of Medicine

https://www.ncbi.nlm.nih.gov/pubmed/16236737


A prospective randomised trial to study the role of levamisole and interferon alfa in an adjuvant therapy with 5-FU for Stage III colon cancer

Schippinger W, Jagoditsch M, Sorré C, Gnant M, Steger G, Hausmaninger H, Mlineritsch B, Schaberl-Moser R, Mischinger HJ, Hofbauer F, Holzberger P, Mittlböck M, Jakesz R

British Journal of Cancer

https://www.ncbi.nlm.nih.gov/pubmed/15856042

2004

Empfehlungen zu Diagnostik und multimodaler Primärtherapie des Rektumkarzinoms 2004

ABCSG, ACO/ASSO, ÖGC, ÖGHO, ÖGP, ÖGRO, ÖRG

Wiener Klinische Wochenschrift 2004.: 10.1007/s00508-005-0323-1

https://www.springermedizin.de/empfehlungen-zu-diagnostik-und-multimodaler-primaertherapie-des-/8563870


Amenorrhoea, aromatase inhibitors, tamoxifen or a combination in premenopausal women.

Jakesz R

European Journal of Cancer

https://cyberleninka.org/article/n/275469


Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer.

Schoppmann SF, Bayer G, Aumayr K, Taucher S, Geleff S, Rudas M, Kubista E, Hausmaninger H, Samonigg H, Gnant M, Jakesz R, Horvat R

Annals of Surgery

https://www.ncbi.nlm.nih.gov/pubmed/15273556


The impact of progesterone receptor in prediction of complete pathological response to preoperative chemotherapy in primary breast cancer patients.

Taucher S, Rudas M, Gnant M, Dubsky P, Sporn E, Roka S, Bachleitner T, Fitzal F, Kandioler D, Wenzel C, Steger G, Draxler W, Mittlböck M, Jakesz R

European Surgery

https://link.springer.com/article/10.1007/s10353-004-0028-0

2003

Incidence of liver metastases in patients receiving adjuvant chemotherapy after lymph node positive primary colon cancer

Gruenberger T, Schwanzer E, Samonigg H, Hausmaninger H, Jakesz R

Journal of Gastrointestinal Surgery


Pelvic radiological imaging: a surgeon’s perspective

Herbst F

European Journal of Radiology

https://www.ncbi.nlm.nih.gov/pubmed/12880994


Significant increase in breast conservation in 16 years of trials conducted by the Austrian Breast & Colorectal Cancer Study Group (ABCSG)

Jakesz R, Samonigg H, Gnant M, Kubista E, Depisch D, Kolb R, Mlineritsch B, Mischinger HJ, Menzel RC, Steindorfer P, Kwasny W, Tausch C, Stierer M, Taucher S, Seifert M, Hausmaninger H

Annals of Surgery

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1514470/


In reply to: Paradigm shift in adjuvant treatment of receptor positive premenopausal breast cancer patients? Not yet.

Jakesz R

Journal of Clinical Oncology


Randomised trial: One cycle of anthracycline-containing adjuvant chemotherapy compared with six cycles of CMF treatment in node-positive, hormone receptor negative breast cancer patients

Ploner F, Jakesz R, Hausmaninger H, Kolb R, Stierer M, Fridrik M, Steindorfer P, Gnant M, Haider K, Mlineritsch B, Tschurtschenthaler G, Steger G, Seifert M, Kubista E, Samonigg H

Onkologie

https://www.ncbi.nlm.nih.gov/pubmed/12771518


High p27 Kip1 expression predicts superior relapse-free and overall survival for premenopausal women with early-stage breast cancer receiving adjuvant treatment with tamoxifen plus goserelin

Pohl G, Rudas M, Dietze O, Lax S, Markis E, Pirker R, Zielinski C, Hausmaninger H, Kubista E, Samonigg H, Jakesz R, Filiptis M

Journal of Clinical Oncology

https://www.ncbi.nlm.nih.gov/pubmed/14512390


Randomized trial of tamoxifen vs tamoxifen plus aminoglutethimide as adjuvant treatment in postmenopausal breast cancer patients with hormone receptor-positive disease: Austrian Breast and Colorectal Cancer Study Group Trial 6.

Schmid M, Jakesz R, Samonigg H, Kubista E, Gnant M, Menzel C, Seifert M, Haider K, Taucher S, Mlineritsch B, Steindorfer P, Kwasny W, Stierer M, Tausch C, Fridrik M, Wette V, Steger G, Hausmaninger H

Journal of Clinical Oncology

https://www.ncbi.nlm.nih.gov/pubmed/12637461


Dendritic Cell-Based Vaccination in Solid Cancer

Stift A, Dubsky P, Bachleitner-Hofmann T, Schueller G, Zontsich T, Benkoe T, Radelbauer K, Brostjan C, Jakesz R, Gnant M

Journal of Clinical Oncology

https://www.ncbi.nlm.nih.gov/pubmed/12506182


Sequential steroid hormone receptor measurements in primary breast cancer with and without intervening primary chemotherapy

Taucher S, Rudas M, Gnant M, Thomanek K, Dubsky P, Roka S, Bachleitner T, Kandioler D, Wenzel C, Steger G, Mittlböck M, Jakesz R

Endocrine-Related Cancer

https://www.ncbi.nlm.nih.gov/pubmed/12653672


Preventive mastectomy in patients at breast cancer risk due to genetic alterations in the BRCA1 and BRCA2 gene

Taucher S, Gnant M, Jakesz R

Langenbecks Archive of Surgery

https://www.ncbi.nlm.nih.gov/pubmed/12690474


Overexpression of Id-1 is associated with poor clinical outcome in node negative breast cancer

Schoppmann SF, Schindl M, Bayer G, Aumayr K, Dienes J, Horvat R, Rudas M, Gnant M, Jakesz R, Birner P

Wiley-Liss DOI 10.1002/ijc.11009

https://www.ncbi.nlm.nih.gov/pubmed/12640673


Impact of pretreatment thromboyctosis on survival in primary breast cancer

Taucher S, Salat A, Gnant M, Kwasny W, Mlineritsch B, Menzel RC, Schmid M, Smola MG, Stierer M, Tausch C, Galid A, Steger G, Jakesz R

Thrombosis & Haemostasis

https://www.ncbi.nlm.nih.gov/pubmed/12783124

2002

Identification of Sentinel Lymph Nodes in Breast Cancer by Lymphoscintingraphy and Gamma Probe Guidance: Dependence on Route of Injection and Tumour Location

Gallowitsch JH, Konstantiniuk P, Jörg L, Urbania A, Kugler F, Peschina W, Hatzl-Griesenhofer M, Zettinig G

European Surgery

https://onlinelibrary.wiley.com/doi/abs/10.1046/j.1563-2563.2002.02072.x


The importance of sentinel node biopsy in breast surgery

Haid A, Schrenk P, Roka S, Tausch C, Pichler-Gebhard B, Rudas M, Zimmermann G

European Surgery

https://onlinelibrary.wiley.com/doi/abs/10.1046/j.1563-2563.2002.02065.x


Chemotherapy versus hormonal adjuvant treatment in premenopausal patients with breast cancer

Jakesz R, Hausmaninger H, Samonigg H

European Journal of Cancer

https://www.ncbi.nlm.nih.gov/pubmed/11818196


Randomized adjuvant trial of tamoxifen and goserelin versus cyclophospamide, methotrexate, and fluorouracil: Evidence for the superiority of treatment with endocrine blockade in premenopausal patients with hormone-responsive breast cancer

Jakesz R, Hausmaninger H, Kubista E, Gnant M, Menzel C, Bauernhofer T, Seifert M, Haider K, Mlineritsch B, Steindorfer P, Kwasny W, Fridrik M, Steger G, Wette V, Samonigg H

Journal of Clinical Oncology

https://www.ncbi.nlm.nih.gov/pubmed/12488405


Standards in der Mamma-Ca-Therapie

Jakesz R

Wiener Klinische Wochenschrift


Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer

Schindl M, Schoppmann F, Samonigg H, Hausmaninger H, Kwasny W, Gnant M, Jakesz R, Kubista E, Birner P, Oberhuber G

Clinical Cancer Research

https://www.researchgate.net/publication/11313017.. Breast_Cancer


Survival of women with breast cancer in Austria by age, stage and period of diagnosis

Vutuc Chr, Waldhoer T, Klimot J, Haidinger G, Jakesz R, Kubist E, Zielinski C

Wiener Klinische Wochenschrift

https://www.ncbi.nlm.nih.gov/pubmed/12422577

2001

Evaluation of the United States Food and Drug Administration approved Scoring and Test System of HER-2 Protein Expression in Breast Cancer

Birner P, Oberhuber G, Stani J, Reithofer C, Samonigg H, Hausmaninger H, Kubista E, Kwasny W, Kandioler-Eckersberger D, Gnant M, Jakesz R

Clinical Cancer Research

https://www.ncbi.nlm.nih.gov/pubmed/11410505


Prognostic relevance of three histological grading methods in breast cancer

Latinovic L, Heinze G, Birner P, Samonigg H, Hausmaninger H, Kubista E, Kwasny W, Gnant M, Jakesz R, Oberhuber G

International Journal of Oncology

https://www.ncbi.nlm.nih.gov/pubmed/11713599

Publikationen der ABCSG (peer reviewed) 2000 und älter